Superbugs vs COVID-19: Comparing the scale and severity of global health threats, preparing for the next health disaster

The rise of drug-resistant superbugs is a serious threat to global health that could surpass the impact of the COVID-19 pandemic. These superbugs, or bacteria and other pathogens that have developed resistance to antibiotics and other antimicrobial drugs, are growing at an alarming rate.

Comparative effects: superbugs vs. COVID-19

In an interview with HT Lifestyle, Dr Shuchin Bajaj, founder and director, Ujala Cygnus Group of Hospitals, revealed that there are several factors behind this phenomenon, including the overuse and misuse of antibiotics in human medicine, agriculture and animal husbandry. The health expert highlights everything you need to know about the growing menace –

1. Scale and severity:

• COVID-19: The COVID-19 pandemic has caused significant disruption globally, leading to millions of deaths and widespread economic and social upheaval. However, the world has also seen the development of effective vaccines and treatments in a relatively short time.
• Superbugs: In contrast, superbugs threaten broader and more lasting impact. Once bacteria become resistant, infections that were previously treatable can become deadly. The medical community is struggling to keep pace with the rapid evolution of these pathogens, and the pipeline for new antibiotics is worryingly sparse.

2. Impact on healthcare:

• COVID-19: Intensive care units (ICUs) were extremely busy, but non-COVID-related healthcare continued with modifications.
• Superbugs: Drug-resistant infections complicate routine surgeries, cancer treatments and chronic disease care, can make even minor infections deadly and overwhelm entire health care systems.

3. Financial burden:

• COVID-19: The short-term economic shocks have been severe, but recovery efforts are underway.
• Superbugs: The long-term economic impact is significant due to increased risk of chronic illness, rising healthcare costs, and lost productivity. The World Bank estimates that by 2050, antimicrobial resistance (AMR) could cost the global economy $100 trillion.

Preventive measures and global response

Talking on how to prepare for the next health disaster, Dr. Shuchin Bajaj suggests –

1. Monitoring and Management: Strengthening global surveillance systems is important to monitor and respond to AMR patterns. Implementing strong antibiotic stewardship programs can help ensure that antibiotics are used responsibly.
2. research and development: Investing in research to develop new antibiotics, alternative treatments and rapid diagnostic tools is essential. Encouraging drug innovation through public-private partnerships can accelerate progress.
3. Public awareness and education: Educating the public and health professionals about the dangers of antibiotic misuse and promoting best practices can help prevent the rise of resistance.
4. Regulatory measures: Governments should impose strict regulations on antibiotic use in agricultural and veterinary practices to reduce unnecessary risks.

Dr. Shuchin Bajaj concluded, “The emergence of drug-resistant superbugs is a crisis that demands urgent and sustained global action. While the COVID-19 pandemic has provided a stark reminder of the fragility of our global health systems, the threat posed by superbugs may be far more insidious and enduring. A multi-pronged approach combining scientific innovation, policy interventions and public engagement is essential to mitigate this threat and protect future generations.”